Article
Development and Validation of a Novel Glycolysis-Related Risk Signature for Predicting Survival in Pancreatic Adenocarcinoma
2020-05-22
Abstract excerpt
<title>Abstract</title> <p>Background Pancreatic adenocarcinoma (PAAD) is one of the leading causes of cancer death worldwide. Through data mining, an increasing number of biomarkers have been identified for predicting survival of PAAD. However, the ability of single gene biomarkers to predict patient survival is still insufficient. This study aimed to develop a novel risk signature for predicting survival of PA...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 67e88cf4-5fb1-5bb4-bc52-b90f18648d62
- DOI
- 10.21203/rs.3.rs-29859/v1
